Evidence map›Paper›PMID 28441409›Full record

ArticlePloS one2017

A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model.

Xuan Yuan, Zhe Li, Andrea C Baines, Eleni Gavriilaki, Zhaohui Ye, Zhexing Wen, Evan M Braunstein, Leslie G Biesecker, Linzhao Cheng, Xinzhong Dong and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. [Glycosylphosphatidylinositol biosynthesis deficiency 15 caused byZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. CDG Therapies: From Bench to Bedside.International journal of molecular sciences · 2018
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xuan YuanDivision of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Zhe LiDepartment of Neuroscience, Johns Hopkins University, School of Medicine, Baltimore, MD, United States of America.
Andrea C BainesDivision of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Eleni GavriilakiDivision of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Zhaohui YeDivision of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Zhexing WenStem Cell Program in the Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Evan M BraunsteinDivision of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Leslie G BieseckerGenetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States of America.
Linzhao ChengDivision of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Xinzhong DongDepartment of Neuroscience, Johns Hopkins University, School of Medicine, Baltimore, MD, United States of America.
Robert A BrodskyDivision of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.ORCID http://orcid.org/0000-0001-5741-1255
Johns Hopkins University · USNational Institutes of Health · US

Funding

Rare & Mosaic Disorders Molecular ResearchZIAHG200328 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BIESECKER, LESLIE · 2009 to 2025
$26.8M
Complementopathies: Genotype and PhenotypeR01HL133113 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI BRODSKY, ROBERT A · 2016 to 2020
$2.0M
NHLBI NIH HHS R01 HL133113
6 · The paper itself

Abstract

Mutations in genes involved in glycosylphosphatidylinositol (GPI) anchor biosynthesis underlie a group of congenital syndromes characterized by severe neurodevelopmental defects. GPI anchored proteins have diverse roles in cell adhesion, signaling, metabolism and complement regulation. Over 30 enzymes are required for GPI anchor biosynthesis and PIGA is involved in the first step of this process. A hypomorphic mutation in the X-linked PIGA gene (c.1234C>T) causes multiple congenital anomalies hypotonia seizure syndrome 2 (MCAHS2), indicating that even partial reduction of GPI anchored proteins dramatically impairs central nervous system development, but the mechanism is unclear. Here, we established a human induced pluripotent stem cell (hiPSC) model containing the PIGAc.1234C>T mutation to study the effects of a hypomorphic allele of PIGA on neuronal development. Neuronal differentiation from neural progenitor cells generated by EB formation in PIGAc.1234C>T is significantly impaired with decreased proliferation, aberrant synapse formation and abnormal membrane depolarization. The results provide direct evidence for a critical role of GPI anchor proteins in early neurodevelopment. Furthermore, neural progenitors derived from PIGAc.1234C>T hiPSCs demonstrate increased susceptibility to complement-mediated cytotoxicity, suggesting that defective complement regulation may contribute to neurodevelopmental disorders.

Indexed as

MutationNeurogenesisAnimalsCell LineComplement System ProteinsCytotoxicity Tests, ImmunologicHematopoiesisHumansInduced Pluripotent Stem CellsMembrane ProteinsMiceNeural Stem CellsNeuronsComplement System ProteinsMembrane Proteinsphosphatidylinositol glycan-class A protein

Identifiers

PMID28441409
PMCPMC5404867
OpenAlexW2608471992

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.